All Stories

  1. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells
  2. TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination
  3. DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment
  4. TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells
  5. RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study
  6. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma
  7. The Role of Survivin in Thyroid Tumors: Differences of Expression in Well-Differentiated, Non–Well-Differentiated, and Anaplastic Thyroid Cancers
  8. Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1
  9. Activation of the RAS/RAF/ERK Signaling Pathway Contributes to Resistance to Sunitinib in Thyroid Carcinoma Cell Lines
  10. Epidermal Growth Factor Receptor 1 Expression Is Upregulated in Undifferentiated Thyroid Carcinomas in Humans
  11. Heat shock proteins, cell survival and drug resistance: The mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy
  12. S100A13 is a new angiogenic marker in human melanoma
  13. Novel Strategies to Improve the Efficacy of Anticancer Agents in Human Colorectal Carcinoma
  14. TRAP1 and SORCIN cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma (CRC)
  15. Targeting Epidermal Growth Factor Receptor 1 Signaling in Human Thyroid-Stimulating Hormone–Independent Thyroid Carcinoma FRO Cells Results in a More Chemosensitive and Less Angiogenic Phenotype
  16. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells
  17. Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo
  18. Nevirapine Toxicity in Non-HIV Cancer Patients
  19. Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma
  20. Reverse Transcriptase Inhibitors Down-Regulate Cell Proliferationin Vitroandin Vivoand Restore Thyrotropin Signaling and Iodine Uptake in Human Thyroid Anaplastic Carcinoma